PubRank

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Clinical Trial ID NCT01493154

PubWeight™ 14.51‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01493154

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 2001 2.61
2 Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation. J Clin Oncol 2009 1.98
3 In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One 2011 1.71
4 Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009 1.38
5 Trial watch: DNA vaccines for cancer therapy. Oncoimmunology 2013 1.11
6 An updated overview of HPV-associated head and neck carcinomas. Oncotarget 2014 1.06
7 Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment. Otolaryngol Clin North Am 2013 0.94
8 The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications. Ann Transl Med 2016 0.93
9 Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol 2013 0.93
10 Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck. Head Neck Pathol 2012 0.90
11 Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells. Cell Biosci 2014 0.90
12 Therapeutic Vaccine Strategies against Human Papillomavirus. Vaccines (Basel) 2014 0.89
13 Preclinical and clinical development of DNA vaccines for prostate cancer. Urol Oncol 2013 0.86
14 Tailored immunotherapy for HPV positive head and neck squamous cell cancer. Oral Oncol 2013 0.84
15 Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology 2015 0.83
16 Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother 2016 0.82
17 Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors. Gene Ther 2015 0.79
18 Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am 2012 0.78
19 Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer. Head Neck Pathol 2012 0.77
20 Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy. Rare Cancers Ther 2015 0.75
21 Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization. Oncotarget 2016 0.75
Next 100